» Articles » PMID: 20144189

Comparative Transfection of DNA into Primary and Transformed Mammalian Cells from Different Lineages

Overview
Journal BMC Biotechnol
Publisher Biomed Central
Specialty Biotechnology
Date 2010 Feb 11
PMID 20144189
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The delivery of DNA into human cells has been the basis of advances in the understanding of gene function and the development of genetic therapies. Numerous chemical and physical approaches have been used to deliver the DNA, but their efficacy has been variable and is highly dependent on the cell type to be transfected.

Results: Studies were undertaken to evaluate and compare the transfection efficacy of several chemical reagents to that of the electroporation/nucleofection system using both adherent cells (primary and transformed airway epithelial cells and primary fibroblasts as well as embryonic stem cells) and cells in suspension (primary hematopoietic stem/progenitor cells and lymphoblasts). With the exception of HEK 293 cell transfection, nucleofection proved to be less toxic and more efficient at effectively delivering DNA into the cells as determined by cell proliferation and GFP expression, respectively. Lipofectamine and nucleofection of HEK 293 were essentially equivalent in terms of toxicity and efficiency. Transient transfection efficiency in all the cell systems ranged from 40%-90%, with minimal toxicity and no apparent species specificity. Differences in efficiency and toxicity were cell type/system specific.

Conclusions: In general, the Amaxa electroporation/nucleofection system appears superior to other chemical systems. However, there are cell-type and species specific differences that need to be evaluated empirically to optimize the conditions for transfection efficiency and cell survival.

Citing Articles

Optimization of chemical transfection in airway epithelial cell lines.

Guo T, Liang W, Singhera G, Memar Vaghri J, Leung J, Dorscheid D BMC Biotechnol. 2025; 25(1):10.

PMID: 39849458 PMC: 11761256. DOI: 10.1186/s12896-025-00945-x.


Ex Vivo Delivery of mRNA to Immune Cells via a Nonendosomal Route Obviates the Need for Nucleoside Modification.

Ghoshal B, Chakraborty D, Nag M, Varadarajan R, Jhunjhunwala S ACS Bio Med Chem Au. 2024; 4(6):291-299.

PMID: 39712209 PMC: 11659889. DOI: 10.1021/acsbiomedchemau.4c00057.


Factors affecting rAAV titers during triple-plasmid transient transfection in HEK-293 cells.

Pistek M, Andorfer P, Grabherr R, Kraus B, Bort J Biotechnol Lett. 2024; 46(6):945-959.

PMID: 39259435 PMC: 11550245. DOI: 10.1007/s10529-024-03520-0.


Ligand-free biodegradable poly(beta-amino ester) nanoparticles for targeted systemic delivery of mRNA to the lungs.

Kavanagh E, Tzeng S, Sharma N, Cutting G, Green J Biomaterials. 2024; 313:122753.

PMID: 39217793 PMC: 11571037. DOI: 10.1016/j.biomaterials.2024.122753.


Plasmid Delivery and Single-Cell Plasmid Expression Analysis for CRISPR/dCas9-Based Epigenetic Editing.

van Saparoea A, van Loosen Q, Sarno F, Ntini E, Rots M, Gjaltema R Methods Mol Biol. 2024; 2842:255-265.

PMID: 39012600 DOI: 10.1007/978-1-0716-4051-7_13.


References
1.
Bruscia E, Sangiuolo F, SINIBALDI P, Goncz K, Novelli G, Gruenert D . Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting. Gene Ther. 2002; 9(11):683-5. DOI: 10.1038/sj.gt.3301741. View

2.
Krause D . Plasticity of marrow-derived stem cells. Gene Ther. 2002; 9(11):754-8. DOI: 10.1038/sj.gt.3301760. View

3.
Maasho K, Marusina A, Reynolds N, Coligan J, Borrego F . Efficient gene transfer into the human natural killer cell line, NKL, using the Amaxa nucleofection system. J Immunol Methods. 2004; 284(1-2):133-40. DOI: 10.1016/j.jim.2003.10.010. View

4.
Liu J, Sung L, Du F, Julian M, Jiang S, Barber M . Differential development of rabbit embryos derived from parthenogenesis and nuclear transfer. Mol Reprod Dev. 2004; 68(1):58-64. DOI: 10.1002/mrd.20045. View

5.
Haleem-Smith H, Derfoul A, Okafor C, Tuli R, Olsen D, Hall D . Optimization of high-efficiency transfection of adult human mesenchymal stem cells in vitro. Mol Biotechnol. 2005; 30(1):9-20. DOI: 10.1385/MB:30:1:009. View